1) Helis CA, Hughes RT, Nieto K, Ufondu A, Daugherty EC, Farris MK.. Adrenal SBRT: a multi-institutional review of treatment outcomes and toxicity. Clin Exp Metastasis. 37(5):585-592, 2020 doi: 10.1007/s10585-020-10052-0
2) Chen WC, Baal JD, Baal U, Pai J, Gottschalk A, Boreta L, Braunstein SE, Raleigh DR. Stereotactic body radiation therapy of adrenal metastases: a pooled meta-analysis and systematic review of 39 studies with 1006 patients. Int J Radiat Oncol Biol Phys. 107(1):48-61, 2020. doi: 10.1016/j.ijrobp.2020.01.017
3) Rudra S, Malik R, Ranck MC, Farrey K, Golden DW, Hasselle MD, Weichselbaum RR, Salama JK. Stereotactic body radiation therapy for curative treatment of adrenal metastases. Technol Cancer Res Treat.12(3):217-224, 2013 doi: 10.7785/tcrt.2012.500320
4) Malone J, Pantarotto JR, Tiberi D, Malone S. Adrenal oligometastasis cured with stereotactic ablative radiotherapy. Radiol Case Rep. 15(11):2266-2270, 2020 doi: 10.1016/j.radcr.2020.08.056
5) König L, Häfner MF, Katayama S, oerber SA, Tonndorf-Martini E, Bernhardt D, von Nettelbladt B, Weykamp F, Hoegen P, Klüter S, Susko MS, Debus J, Hörner-Rieber J. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients. Radiat Oncol. 15(1):30, 2020 doi: 10.1186/s13014-020-1480-0
6) Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J, Flynn RT, Bhatia SK, Smith MC, Buatti JM, Allen BG. SBRT to adrenal metastases provides high local control with minimal toxicity. Adv Radiat Oncol. 2(4):581-587, 2017 doi: 10.1016/j.adro.2017.07.011
7) Figura NB, Oliver DE, Mohammadi H, Martinez K, Grass GD, Hoffe SE, Johnstone PAS, Frakes JM. Novel dose escalation approaches for stereotactic body radiotherapy to adrenal oligometastases: a single-institution experience. Am J Clin Oncol. 43(2):107-114, 2020
8) Voglhuber T, Kessel KA, Oechsner M, Vogel MME, Gschwend JE, Combs SE. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases. BMC Cancer. 20(1):536, 2020 doi: 10.1186/s12885-020-07030-w
9) Buergy D, Rabe L, Siebenlist K, Stieler F, Fleckenstein J, Giordano FA, Wenz F, Boda-Heggemann J. Treatment of adrenal metastases with conventional or hypofractionated image-guided radiation therapy - patterns and outcomes. J Anticancer Res. 38(8):4789-4796, 2018 doi: 10.21873/anticanres.12788
10) Sonier M, Chu W, Lalani N, Erler D, Cheung P, Korol R. Implementation of a volumetric modulated arc therapy treatment planning solution for kidney and adrenal stereotactic body radiation therapy. Med Dosim. 41(4):323-328, 2016 doi: 10.1016/j.meddos.2016.09.001
11) Arcidiacono F, Aristei C, Marchionni A, Italiani M, Fulcheri CPL, Saldi S, Casale M, Ingrosso G, Anselmo P, Maranzano E. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients. Br J Radiol. 93(1115):20200645, 2020 doi: 10.1259/bjr.20200645
12) Melissa de Kuijer , Jaap van Egmond , E Kouwenhoven , Dieke Bruijn-Krist , Heleen Ceha , Mirjam Mast. Breath-hold versus mid-ventilation in SBRT of adrenal metastases. Tech Innov Patient Support Radiat Oncol. 16;12:23-27, 2019 doi: 10.1016/j.tipsro.2019.11.007.
13) McPartlin AJ, Li XA, Kershaw LE Heide U, Kerkmeijer L, Lawton C, Mahmood U, Pos F, van As N, van Herk M, Vesprini D, van der Voort van Zyp J, Tree A, Choudhury A; MR-Linac consortium. MRI-guided prostate adaptive radiotherapy – A systematic review, Radiother Oncol. 119(3), 371-80, 2016. DOI: 10.1016/j.radonc.2016.04.014
14) Cao Y, Tseng CL, Balter JM, Teng F, Parmar HA, Sahgal A. MR-guided radiation therapy: transformative technology and its role in the central nervous system, Neuro-Oncology, 19, ii16–ii29, 2017.
15) van Sörnsen de Koste JR, Palacios MA, Chen H, Schneiders FL, Bruynzeel AME, Slotman BJ, Haasbeek CJA, Senan S. Changes in gastric anatomy after delivery of breath-hold MR-guided SABR for adrenal metastases. Radiother Oncol. 152:26-29, 2020 doi: 10.1016/j.radonc.2020.07.045.
16) König L, Häfner MF, Katayama S, Koerber SA, Tonndorf-Martini E, Bernhardt D, von Nettelbladt B, Weykamp F, Hoegen P, Klüter S, Susko MS, Debus J, Hörner-Rieber J. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients. Radiat Oncol. 4;15(1):30. 2020 DOI: 10.1186/s13014-020-1480-0
17) Tanaka O, Sugiyama A, Omatsu T, Tawada M, Makita C, Matsuo M. Hemostasis radiotherapy for inoperable gastric cancer: A pilot study. Br J Radiol, 93;20190958, 2020